Rallybio Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 24, 2022, details the results of Rallybio Corporation's annual meeting of shareholders held on that date. The company is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol RLYB.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance matters.
Material Changes and Voting Results
The filing reports the following outcomes from the shareholder vote:
- Director Elections: Three nominees were elected as Class I directors for terms expiring at the 2025 annual meeting:
- Martin W. Mackay: 16,028,966 votes For; 297,302 Withheld.
- Kush M. Parmar: 15,217,584 votes For; 1,108,684 Withheld.
- Paula Soteropoulos: 16,037,821 votes For; 288,447 Withheld.
- Accounting Firm Ratification: Shareholders ratified the appointment of Deloitte and Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Votes For: 18,045,373
- Votes Against: 1,035
- Votes Abstain: 508
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following the election of the three Class I directors.
- Confirm the engagement of Deloitte and Touche LLP for the 2022 fiscal year audit.
- Note the presence of broker non-votes (1,720,648) on the director election proposals, which did not affect the outcome but indicate shares held in street name where instructions were not received.